The Global Oncology Information Systems Market Size accounted for USD 3.8 Billion in 2021 and is projected to occupy a market size of USD 7.5 Billion by 2030 growing at a CAGR of 7.9% from 2022 to 2030.
Oncology information systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall healthcare organizations. Furthermore, these advantages improve the efficiency and safety of cancer therapy for patients. Oncology information systems help surgeons and physicians to choose the most suitable therapy to develop the survival rate for cancer patients.
Oncology Information Systems Market Report Statistics
- Global oncology information systems market revenue is estimated to reach USD 7.5 Billion by 2030 with a CAGR of 7.9% from 2022 to 2030
- North America oncology information systems market share generated over 39% shares in 2021
- According to National Cancer Institute, the US congress offered over USD 6.9 billion during the annual federal budgeting process
- Asia-Pacific oncology information systems market growth will record substantial CAGR of over 8.5% from 2022 to 2030
- Based on product & services, solutions captured around 74% of the overall market share in 2021
- Among applications, medical oncology generated shares of over 62% in 2021
- Growing healthcare IT industry is a popular oncology information systems market trend that is fueling the industry demand
Global Oncology Information Systems Market Dynamics
Market Drivers
- Growing prevalence and incidence of cancer
- Increasing adoption of EHR and other healthcare IT solutions
- Favorable government support and initiatives for oncology information systems
Market Restraints
- Lack of skilled healthcare IT professionals
- Data privacy and interoperability issues
Market Opportunities
- Rising technological advancements in these systems
- Integration of EMR with treatment planning systems
Oncology Information Systems Market Report Coverage
| Market |
Oncology Information Systems Market |
| Oncology Information Systems Market Size 2021 |
USD 3.8 Billion |
| Oncology Information Systems Market Forecast 2030 |
USD 7.5 Billion |
| Oncology Information Systems Market CAGR During 2022 - 2030 |
7.9% |
| Oncology Information Systems Market Analysis Period |
2018 - 2030 |
| Oncology Information Systems Market Base Year |
2021 |
| Oncology Information Systems Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Product & Services, By Application, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., and ViewRay Inc. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Oncology Information Systems Market Growth Factors
The key factors that drive the market growth include ease of use of different cancer therapies, such as radiation therapy, and chemotherapy, and the existence of a huge cancer population. During the envisaged period, the market is likely to witness moderate growth, due to the benefits offered by oncology information systems over conventional methods of record keeping and treatment planning. The factors that are anticipated to boost the market growth include the surge in the prevalence of cancer and rising in technological advancements, such as incorporation of patients portals. Furthermore, there are various opportunities for expanding markets such as the use of oncology information systems to treat rare cancer and advance improvements in the technology by the use of artificial intelligence. However, the factors likely to hinder the market growth include lack of healthcare IT professionals and high costs associated with oncology information systems.
Oncology Information Systems Market Segmentation
The global oncology information systems market is segmented based on product & services, application, and geography.
Oncology Information Systems Market By Product & Services
- Solutions
- Patient Information Systems
- Treatment Planning Systems
- Professional Services
The global oncology information systems industry analysis, the solutions segment accounted for more than 2/3rd of the market share in 2021 and is likely to do so in the coming years. The large market share of this industry sector is primarily explained by the growing need to control the costs of oncology care, which are continuing to rise, and to enhance the effectiveness of oncology care services by lowering medical errors.
Oncology Information Systems Market By Application
- Medical Oncology
- Surgical Oncology
- Radiation Oncology
According to the oncology information systems market forecast, the medical oncology application will account for a significant portion of the market from 2022 to 2030. Due to rapid advancements in hormonal therapy, immunotherapy, and targeted therapy for efficiently treating various cancers, the medical oncology segment is expected to grow at the fastest CAGR over the forecast period. During the forecast years, the surgical oncology segment is also expected to grow significantly. Cancer treatment has advanced rapidly in recent decades.
Oncology Information Systems Market By End-User
- Hospitals & Diagnostic Imaging Centers
- Ablation Care Centers and Cancer Care Centers
- Government Institutions
- Research Facilities
The hospitals & oncology clinics segment controlled the oncology information systems market in 2021 and is expected to continue dominating during the forecast period, owing to an increase in the number of cancer cases and patients visits to hospitals and clinics. End-user segments of the oncology information system market include hospitals and diagnostic imaging centers, ablation and cancer care centers, government institutions, and research facilities.
Oncology Information Systems Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Oncology Information Systems Market Regional Analysis
For each region, the market size and volume for different segments has been covered under the scope of report. North America region is accounted for the largest share of the oncology information systems market, followed by Europe in present years. Furthermore, the Asia-Pacific market is likely to grow at the highest CAGR during the upcoming period due to high growth can be attributed to the increasing focus of the market players on developing nations.
Oncology Information Systems Market Players
Some of the global oncology information systems companies included in the report are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., and ViewRay Inc.
CHAPTER 1. Industry Overview of Oncology Information Systems Market
1.1. Definition and Scope
1.1.1. Definition of Oncology Information Systems
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Oncology Information Systems Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Oncology Information Systems Market By Product & Services
1.2.3. Oncology Information Systems Market By Application
1.2.4. Oncology Information Systems Market By End-User
1.2.5. Oncology Information Systems Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Oncology Information Systems Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Oncology Information Systems Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Oncology Information Systems Market By Product & Services
4.1. Introduction
4.2. Oncology Information Systems Revenue By Product & Services
4.2.1. Oncology Information Systems Revenue (USD Billion) and Forecast, By Product & Services, 2018-2030
4.2.2. Solutions
4.2.2.1. Solutions Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Patient Information Systems
4.2.2.2.1. Patient Information Systems Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Treatment Planning Services
4.2.2.3.1. Treatment Planning Services Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Professional Services
4.2.3.1. Professional Services Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Oncology Information Systems Market By Application
5.1. Introduction
5.2. Oncology Information Systems Revenue By Application
5.2.1. Oncology Information Systems Revenue (USD Billion) and Forecast, By Application, 2018-2030
5.2.2. Medical Oncology
5.2.2.1. Medical Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Surgical Oncology
5.2.3.1. Surgical Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Radiation Oncology
5.2.4.1. Radiation Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Oncology Information Systems Market By End-User
6.1. Introduction
6.2. Oncology Information Systems Revenue By End-User
6.2.1. Oncology Information Systems Revenue (USD Billion) and Forecast, By End-User, 2018-2030
6.2.2. Hospitals & Diagnostic Imaging Centers
6.2.2.1. Hospitals & Diagnostic Imaging Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Ablation Care Centers and Cancer Care Centers
6.2.3.1. Ablation Care Centers and Cancer Care Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Government Institutions
6.2.4.1. Government Institutions Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Research Facilities
6.2.5.1. Research Facilities Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Oncology Information Systems Market By Country
7.1. North America Oncology Information Systems Market Overview
7.2. U.S.
7.2.1. U.S. Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
7.2.2. U.S. Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
7.2.3. U.S. Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.3. Canada
7.3.1. Canada Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
7.3.2. Canada Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
7.3.3. Canada Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Oncology Information Systems Market By Country
8.1. Europe Oncology Information Systems Market Overview
8.2. U.K.
8.2.1. U.K. Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
8.2.2. U.K. Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
8.2.3. U.K. Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Germany
8.3.1. Germany Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
8.3.2. Germany Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
8.3.3. Germany Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. France
8.4.1. France Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
8.4.2. France Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
8.4.3. France Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.5. Spain
8.5.1. Spain Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
8.5.2. Spain Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
8.5.3. Spain Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
8.6.2. Rest of Europe Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
8.6.3. Rest of Europe Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Oncology Information Systems Market By Country
9.1. Asia Pacific Oncology Information Systems Market Overview
9.2. China
9.2.1. China Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.2.2. China Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.2.3. China Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Japan
9.3.1. Japan Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.3.2. Japan Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3.3. Japan Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. India
9.4.1. India Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.4.2. India Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.4.3. India Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Australia
9.5.1. Australia Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.5.2. Australia Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.5.3. Australia Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.6.2. South Korea Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.6.3. South Korea Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
9.7.2. Rest of Asia-Pacific Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
9.7.3. Rest of Asia-Pacific Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Oncology Information Systems Market By Country
10.1. Latin America Oncology Information Systems Market Overview
10.2. Brazil
10.2.1. Brazil Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
10.2.2. Brazil Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
10.2.3. Brazil Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Mexico
10.3.1. Mexico Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
10.3.2. Mexico Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3.3. Mexico Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
10.4.2. Rest of Latin America Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4.3. Rest of Latin America Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Oncology Information Systems Market By Country
11.1. Middle East & Africa Oncology Information Systems Market Overview
11.2. GCC
11.2.1. GCC Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
11.2.2. GCC Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
11.2.3. GCC Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. South Africa
11.3.1. South Africa Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
11.3.2. South Africa Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3.3. South Africa Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Oncology Information Systems Revenue (USD Billion) and Forecast By Product & Services, 2018-2030
11.4.2. Rest of Middle East & Africa Oncology Information Systems Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4.3. Rest of Middle East & Africa Oncology Information Systems Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Oncology Information Systems Market
12.1. Oncology Information Systems Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product & Services Launches and Product & Services Enhancements
12.2.3. Mergers And Acquisition In Global Oncology Information Systems Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Elekta AB
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Elekta AB 2021 Oncology Information Systems Business Regional Distribution
13.1.4. Product & Services /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Varian Medical Systems
13.3. Accuray Incorporated
13.4. Cerner Corporation
13.5. RaySearch Laboratories
13.6. Flatiron
13.7. Cerner Corp.
13.8. BrainLab
13.9. Philips Healthcare
13.10. Prowess, Inc.
13.11. DOSIsoft S.A.
13.12. ViewRay Inc.
